-
1دورية أكاديمية
المؤلفون: Lebeau, Rodolphe, H, Mendez-David, Indira, Kucynski-Noyau, Laura, Henry, Céline, Attali, David, Plaze, Marion, Colle, Romain, Corruble, Emmanuelle, Gardier, Alain, M, Gaillard, Raphaël, Guilloux, Jean-Philippe, David, Denis, J
المساهمون: Université Paris-Saclay, MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Sainte Anne Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre
المصدر: ISSN: 1663-9812 ; Frontiers in Pharmacology ; https://hal.inrae.fr/hal-04098898Test ; Frontiers in Pharmacology, 2022, 13, ⟨10.3389/fphar.2022.993449⟩.
مصطلحات موضوعية: electroconvulsive therapy, fluoxetine, non-response, peripheral biomarkers, major depressive disorder, difficult to treat depression, electroconvulsive therapy fluoxetine non-response peripheral biomarkers major depressive disorder difficult to treat depression, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36386166; hal-04098898; https://hal.inrae.fr/hal-04098898Test; https://hal.inrae.fr/hal-04098898/documentTest; https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest; PUBMED: 36386166; WOS: 000885071400001
الإتاحة: https://doi.org/10.3389/fphar.2022.993449Test
https://hal.inrae.fr/hal-04098898Test
https://hal.inrae.fr/hal-04098898/documentTest
https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest -
2دورية أكاديمية
المؤلفون: Lebeau, Rodolphe, H, Mendez-David, Indira, Kucynski-Noyau, Laura, Henry, Céline, Attali, David, Plaze, Marion, Colle, Romain, Corruble, Emmanuelle, Gardier, Alain, M, Gaillard, Raphaël, Guilloux, Jean-Philippe, David, Denis, J
المساهمون: Université Paris-Saclay, MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Sainte Anne Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre
المصدر: ISSN: 1663-9812 ; Frontiers in Pharmacology ; https://hal.inrae.fr/hal-04098898Test ; Frontiers in Pharmacology, 2022, 13, ⟨10.3389/fphar.2022.993449⟩.
مصطلحات موضوعية: electroconvulsive therapy, fluoxetine, non-response, peripheral biomarkers, major depressive disorder, difficult to treat depression, electroconvulsive therapy fluoxetine non-response peripheral biomarkers major depressive disorder difficult to treat depression, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36386166; hal-04098898; https://hal.inrae.fr/hal-04098898Test; https://hal.inrae.fr/hal-04098898/documentTest; https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest; PUBMED: 36386166; WOS: 000885071400001
الإتاحة: https://doi.org/10.3389/fphar.2022.993449Test
https://hal.inrae.fr/hal-04098898Test
https://hal.inrae.fr/hal-04098898/documentTest
https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest -
3دورية أكاديمية
المؤلفون: Lebeau, Rodolphe, H, Mendez-David, Indira, Kucynski-Noyau, Laura, Henry, Céline, Attali, David, Plaze, Marion, Colle, Romain, Corruble, Emmanuelle, Gardier, Alain, M, Gaillard, Raphaël, Guilloux, Jean-Philippe, David, Denis, J
المساهمون: Université Paris-Saclay, MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Sainte Anne Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)
المصدر: ISSN: 1663-9812 ; Frontiers in Pharmacology ; https://hal.inrae.fr/hal-04098898Test ; Frontiers in Pharmacology, 2022, 13, ⟨10.3389/fphar.2022.993449⟩.
مصطلحات موضوعية: electroconvulsive therapy, fluoxetine, non-response, peripheral biomarkers, major depressive disorder, difficult to treat depression, electroconvulsive therapy fluoxetine non-response peripheral biomarkers major depressive disorder difficult to treat depression, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36386166; hal-04098898; https://hal.inrae.fr/hal-04098898Test; https://hal.inrae.fr/hal-04098898/documentTest; https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest; PUBMED: 36386166; WOS: 000885071400001
الإتاحة: https://doi.org/10.3389/fphar.2022.993449Test
https://hal.inrae.fr/hal-04098898Test
https://hal.inrae.fr/hal-04098898/documentTest
https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest -
4دورية أكاديمية
المؤلفون: Lebeau, Rodolphe, H, Mendez-David, Indira, Kucynski-Noyau, Laura, Henry, Céline, Attali, David, Plaze, Marion, Colle, Romain, Corruble, Emmanuelle, Gardier, Alain, M, Gaillard, Raphaël, Guilloux, Jean-Philippe, David, Denis, J
المساهمون: Université Paris-Saclay, MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Sainte Anne Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre
المصدر: ISSN: 1663-9812 ; Frontiers in Pharmacology ; https://hal.inrae.fr/hal-04098898Test ; Frontiers in Pharmacology, 2022, 13, ⟨10.3389/fphar.2022.993449⟩.
مصطلحات موضوعية: electroconvulsive therapy, fluoxetine, non-response, peripheral biomarkers, major depressive disorder, difficult to treat depression, electroconvulsive therapy fluoxetine non-response peripheral biomarkers major depressive disorder difficult to treat depression, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36386166; hal-04098898; https://hal.inrae.fr/hal-04098898Test; https://hal.inrae.fr/hal-04098898/documentTest; https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest; PUBMED: 36386166; WOS: 000885071400001
الإتاحة: https://doi.org/10.3389/fphar.2022.993449Test
https://hal.inrae.fr/hal-04098898Test
https://hal.inrae.fr/hal-04098898/documentTest
https://hal.inrae.fr/hal-04098898/file/2022_Lebeau_Front_Pharmacol.pdfTest